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Transforming Growth Factor β (TGFβ) was first identified for its ability to induce anchorage-independent growth (Roberts et al., 1981) and is the founding member of the 
largest family of secreted morphogens in mammals. The TGFβ family is divided into distinct classes, based on biological function, that include activins, inhibins, bone 
morphogenetic proteins (BMPs), and Mullerian-inhibiting substance (MIS) (Laiho and Keski-Oja, 1992). Signaling by all TGFβ family members occurs via transmembrane 
serine/threonine kinases that upon ligand binding form a heteromeric complex of type II and type I receptors (reviewed in Shi and Massague, 2003). In the eponymous TGFβ 
pathway this occurs via ligand-induced cooperative assembly of the receptor complex, thus allowing the kinase domain of the type II receptor to phosphorylate the type I 
receptor, as well as other receptor-bound components. In the canonical pathway, signaling to the transcriptional machinery is transduced by a unique family of intracellular 
signaling mediators called Smads (Heldin et al., 1997). Phosphorylation of the type I receptor by the type II kinase thus activates Smad signaling, likely by creating a docking 
site on the type I kinase for binding of the receptor-regulated class of Smads (R-Smad2/3) (Huse et al., 2001). Once bound to the type I receptor, R-Smads are phosphory-
lated on the last two serines at a conserved carboxy-terminal SSXS motif. This induces dissociation from the receptor complex, drives assembly of R-Smads into a complex 
with a second class of Smads, the so-called co-Smad (Smad4), and leads to the nuclear accumulation of heteromeric Smad complexes. In the nucleus, Smads regulate 
transcription of TGFβ target genes by interacting with a broad range of DNA-binding partners. One transcriptional target of Smad signaling is a third class of Smads, called 
the inhibitory Smads (I-Smads) of which Smad7 is a potent inhibitor of TGFβ signaling (Hayashi et al., 1997; Nakao et al., 1997). Smad7 acts in a negative feedback loop 
to inhibit Smad activation and recruits the E3 ubiquitin ligases, Smad Ubiquitin Regulatory Factors 1/2 (Smurf 1/2), to the receptor complex to mediate receptor turnover 
(reviewed in Izzi and Attisano, 2004).
In this SnapShot we show that the core components of this canonical TGFβ-Smad pathway are embedded within a large network of physical protein-protein interactions that 
play key roles in mediating the complex biology of TGFβ. At the level of the receptor, TGFβ binds accessory receptors (such as TGFBRIII and endoglin) to facilitate ligand 
binding and other intracellular partners involved in non-Smad signaling pathways (top left nodes). Trafficking of TGFβ receptors has emerged as a key regulator of Smad 
signaling (Le Roy and Wrana, 2005) and is reflected in the association of the receptors with numerous components of the trafficking system (green nodes). The receptor 
complex and Smurfs also bind Par6 and other components of the polarity complex (blue nodes), thereby regulating apical-basal polarity during epithelial-to-mesenchymal 
transition. In the nucleus, the Smad 2/3/4 complex associates with a broad range of DNA-binding partners (orange nodes), which recruit Smads to regulatory elements of 
target genes. Smads in turn regulate transcriptional output by coupling to core transcriptional cofactors (e.g., p300, ARC105, BRG1, etc.; pink nodes). Cell type specificity 
in Smad DNA-binding partner expression and the role of many of these Smad partners in other signaling pathways is proposed to confer tremendous diversity in the TGFβ 
transcriptional response (Feng and Derynck, 2005). The Smad pathway also directly engages in signal transduction crosstalk with other well-described pathways (e.g., AKT1 
and ERK; yellow nodes). All interactions in this diagram are taken from literature-curated sources. PubMed IDs for the literature sources of each interaction as well as a 
Cytoscape compatible file of these interactions can be found at http://dynactome.mshri.on.ca/tgfb/TGFbeta%20interactome%20040108.xls.
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